View in EDS

Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia.

Saved in:
Bibliographic Details
Title: Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia.
Authors: Tamellini E; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy., Sorio M; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Andreini A; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Tecchio C; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Nadali G; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Bernardelli A; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Ferrarini I; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Crosera L; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Vatteroni A; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Simio C; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Benedetti F; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Krampera M; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy., Tanasi I; Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
Source: Blood cell therapy [Blood Cell Ther] 2024 Jun 14; Vol. 7 (3), pp. 75-78. Date of Electronic Publication: 2024 Jun 14 (Print Publication: 2024).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Asia-Pacific Blood and Marrow Transplantation Country of Publication: Japan NLM ID: 9918333884906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2432-7026 (Electronic) Linking ISSN: 24327026 NLM ISO Abbreviation: Blood Cell Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2432-7026
DOI:10.31547/bct-2024-005